Brief: Astria Therapeutics Receives Fast Track Designation For STAR-0215
20/07/2023 13:36
July 20 (Reuters) - Astria Therapeutics Inc ATXS.O :
* ASTRIA THERAPEUTICS RECEIVES FAST TRACK DESIGNATION FOR
STAR-0215 FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
* ON TRACK FOR PROOF-OF-CONCEPT RESULTS IN HAE PATIENTS IN
MID-2024
Source text for Eikon: ID:nBw3v1Dcva
Further company coverage: ATXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astria Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:59 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM